Elliot Ehrich Insider Trading
Get free email notifications about insider trading for Elliot Ehrich.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Elliot Ehrich. Elliot Ehrich is a SVP, R&D & Chief Medical Ofcr in ALKERMES INC ($ALKS) and a VP, Science and Development in ALKERMES INC ($ALKS) and a EVP, R&D & CMO, Alkermes, Inc. in Alkermes plc. ($ALKS).
Address: 88 SIDNEY STREET CAMBRIDGE 02139 MA
Companies in which Elliot Ehrich is an Insider
ALKERMES INC
Trading Symbol: ALKSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Elliot Ehrich: SVP, R&D & Chief Medical Ofcr, VP, Science and Development
Holdings: 40,079 shares
Current Value: $2,195,127
Latest Transaction: Jan 27 2010
$ALKS Market Capitalization: $8.27B
$ALKS Previous Close: $54.77
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Alkermes plc.
Trading Symbol: ALKSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Elliot Ehrich: EVP, R&D & CMO, Alkermes, Inc.
Holdings: 58,821 shares
Current Value: $3,221,626
Latest Transaction: May 30 2017
$ALKS Market Capitalization: $8.28B
$ALKS Previous Close: $54.77
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Elliot Ehrich
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 30 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 0 | |
May 30 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 57.70 | 1,765 | 101,841 | 57,056 | 58.8 K to 57.1 K (-3.00 %) |
May 30 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 58,821 | 55.1 K to 58.8 K (+6.81 %) |
Apr 18 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 16.55 | 10,000 | 165,500 | 9,801 | |
Apr 18 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 56.60 | 10,000 | 565,986 | 55,071 | 65.1 K to 55.1 K (-15.37 %) |
Apr 18 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 16.55 | 10,000 | 165,500 | 65,071 | 55.1 K to 65.1 K (+18.16 %) |
Mar 16 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 16.55 | 10,000 | 165,500 | 19,801 |